Efficient arrhythmia diagnostics with lower operational cost.
Technology your patients recommend.
Guaranteed satisfaction: patients complete the test and recommend your service.
The best experience
ZERO maintenance
NPS 95.9
Cardiac monitor, event recorder and telemetry in a single device.
Better clinical outcomes
99% accuracy in identifying Atrial Fibrillation or Flutter. 7
Long-term tests with a 1.6 times higher diagnostic rate for severe arrhythmias. 4
Artificial Intelligence analysis, providing greater data analysis. 7
Easier operation
No management of cables, batteries, or SD cards.
Signal qualification at the time of installation via telemetry.
Online test transmission, bringing more agility to analysis.
Greater patient satisfaction
4x more comfortable than the conventional Holter. 7
100% greater comfort for daily activities.
Covered by health insurance for 24-hour tests in Brazil. 11
An easier and more qualified single solution for cardiac monitoring, expanding your service offering
Diagnoses enhanced by Artificial Intelligence.
Identifies anomalies imperceptible to the human eye.10
Real-time capture and transmission via Bluetooth
Fast analysis of large volumes of data 10
Identification of arrhythmia patterns 10
99% accuracy in identifying Atrial Fibrillation (AF) 7
ZERO initial investment
Technical support and training included in the subscription
Device replacement if necessary
Devices and charger at no additional cost
Payment per test performed
1 in 10 clinics already uses QuoreOne in Brazil
Today I can say that at Lapacor we have the most modern and comfortable Holter on the market. In 3 months of operation, we increased Holter exam capacity by 40% and reduced installation time by 20%.
Cristina Pedrassi - Administrator at Lapacor
Why are so many clinics and hospitals switching to QuoreOne?
100% reduction in maintenance costs.
Reduction in time between test prescription and report, from weeks to 15 minutes.
Cloud-based test analysis platform, allowing agility in report generation.
Zero initial investment: subscription model that preserves working capital.
Greater patient satisfaction: NPS of 95.9.
Technical support and training for the entire team included.
40% increase in exam capacity with a 20% reduction in installation time, according to our clients.
Recurring revenue: over 90% contract renewal rate.
Immediate scalability: add devices as your demand grows.
References
1. Worldometer, Current World Population, disponível em: [https://www.worldometers.info/world-population/], acesso em 25Abr2025
2. Karamitanha F., et al, Difference Between Various Countries in Mortality and Incidence Rate of the Atrial Fibrillation Based on Human Development Index in Worldwide: Data From Global Burden of Disease 2010-2019, Current Problems in Cardiology Volume 48, Issue 1, January 2023, 101438
3. Van Gelder I. C, et al, 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), European Heart Journal (2024) 00, 1-101, https://doi.org/10.1093/eurheartj/ehae176 and Risks, 1990-2022100000.
4.Known S., et al, Comparison Between the 24-hour Holter Test and 72-hour Single-Lead Electrocardiogram Monitoring With an Adhesive Patch-Type Device for Atrial Fibrillation Detection: Prospective Cohort Study, J Med Internet Res. 2022 May; 24(5): e37970. Published online 2022 May 9. doi:
10.2196/37970: 10.2196/37970.
5. Kim J. Y., et al, The efficacy of detecting arrhythmia is higher with 7-day continuous electrocardiographic patch monitoring than with 24-h Holter monitoring, Journal of Arrhthmia, Received: 3 January 2023 | Revised: 13 April 2023 | Accepted: 20 April 2023, DOI: 10.1002/joa3.12865.
6. Cadastro Nacional de Estabelecimentos de Saúde (CNES), Consulta Estabelecimentos, Nome com “COR” ou “CARDIO”, mediana dos estabelecimentos, disponível em: [https://cnes.datasus.gov.br/], acesso em 02Maio2025.
7. Hospital Israelita Albert Einsteim, A Comparative study of an innovative 3-lead wireless water resistant Holter system and a conventional Holter system, disponível em: [https://clinicaltrials.gov/study/NCT04723355?term=Quoretech&rank=1]; acesso em
8. Data on File, Quoretech Jul/21 onde 44,4%
9. Yenikomshian M., et al, Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review, Curr Med Res Opin. 2019 Oct;35(10):1659-1670. doi: 10.1080/03007995.2019.1610370. Epub 2019 May 28.
10. Leclercq C., et al, Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: Proceedings of the European Society of Cardiology Cardiovascular Round Table, EP Europace, Volume 24, Issue 9, September 2022, Pages 1372-1383, https://doi.org/10.1093/europace/euac05
11. ROL_ANS, disponível em: [https://www.ans.gov.br/ROL-web/pages/cobertura.xhtml], acesso em: 25Abr2025
12. SOBRAC, A vida de um portador de arrimtia cardíaca, disponível em: [https://sobrac.org/publico-
geral/sdrfvesfvs/], acesso em 25Abr2025
13. ANS, Procedimentos 2023, disponível em: [https://app.powerbi.com/view?r=eyJrIjoiNzIxNz|4MjItZTEwNyO0NmQ2LTk3ZTktZDNjYjA5Zjk2MTIOliwid
Cl6ljlkYmEOODBjLTRmYTctNDJmNC1iYmEzLTBmYjEzNzVmYmU1ZiJ9], acesso em 25Abr2025
14. DATASUS, PRODUÇÃO AMBULATORIAL DO SUS – BRASIL – POR LOCAL DE ATENDIMENTO, HOLTER, disponível em: [http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sia/cnv/qabr.def], acesso em 25Abr2025
